|
In tens, please (ten pound notes) http://ukyankee.com/delta-fly-pharma-pipeline-94dd.pdf delta-fly pharma inc “The substantial second-half gain that we were counting onin our view of EPS will not likely close at the end of thisyear, but we’re still in active discussions,†Chief FinancialOfficer Mark Loughridge said on a conference call. “As youknow, we have a very disciplined M&A process. We’re not going tounderprice or rush a divestiture simply to close within 2013.â€ÂÂ
|